Pharmacy

Helping members save on prescriptions with Rx Savings Solutions.

This month’s newsletter highlights biosimilars’ value, high-cost low-value drug guidance, and key formulary updates for prior authorization, step therapy, and limits.

A quick look at what you need to know for RxDC reporting—plus a critical April 24 deadline you can’t miss.

With GLP 1s still dominating headlines and coverage evolving, this month’s update highlights what you need to know about rising demand and new market developments.

Find out which drugs will require prior authorization and the preferred alternatives.

The White House announced new agreements with certain drugmakers to lower prices on some popular medications.